London, United Kingdom
Flo Health Inc., founded in 2015, is an innovative leader in the AI, Health Care, and Women's Health sectors, based in the United Kingdom. The company’s mission, encapsulated by its slogan, "We are building a better future for female health by helping our users harness the power of their body signals," underlines its focus on empowering women globally. With over 400 million women utilizing its capabilities, Flo's app serves as the world's leading period and ovulation tracker.
Highlighting its robust market presence, Flo reports 77 million monthly active users, including a significant 25% of women in the US, propelling it to the forefront of femtech. The company achieved its status as the first European femtech unicorn with a substantial $230M Series C investment in July 2024, illustrating strong investor confidence.
Flo Health addresses three key areas: expanding access through strategic partnerships, improving health literacy, and advancing women's health research. Additionally, its commitment to data privacy with the groundbreaking Anonymous Mode feature underscores its dedication to safeguarding users’ personal information.
The Lowdown
